Nektar Therapeutics | NKTR - EPS Earnings Per Share


Nektar Therapeutics reported $-1.35 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.





Eps Change Date
Agios Pharmaceuticals USD -1.69 0.17 Mar/2026
ALKERMES USD -0.4 0.69 Mar/2026
Alterity Therapeutics Limited AUD 0 0 Dec/2025
Amgen USD 5.15 0.14 Mar/2026
Baxter International USD 0.36 0.08 Mar/2026
BioCryst Pharmaceuticals USD 1.17 1.1 Dec/2025
Biogen USD 3.57 1.58 Mar/2026
Bristol-Myers Squibb USD 1.58 0.32 Mar/2026
Cara Therapeutics USD -0.59 4.45 Sep/2025
Cipla INR 6.86 8.34 Mar/2026
Dr.Reddys Laboratories INR 5.8 8.72 Mar/2026
Eisai JPY -11.53 72.47 Mar/2026
Eli Lilly USD 8.55 1.01 Mar/2026
Esperion Therapeutics USD 0.26 0.42 Dec/2025
Exelixis USD 0.87 0.1 Mar/2026
Gilead Sciences USD 2.03 0.17 Mar/2026
GlaxoSmithKline GBP 0.43 0.17 Mar/2026
Grifols EUR 0.16 0.02 Mar/2026
Halozyme Therapeutics USD 1.6 1.84 Mar/2026
Incyte USD 1.81 0.01 Mar/2026
Ionis Pharmaceuticals USD -0.56 0.85 Mar/2026
Ironwood Pharmaceuticals USD 0.24 0.25 Mar/2026
Karyopharm Therapeutics USD -2.22 2.07 Dec/2025
MacroGenics USD -0.58 0.36 Mar/2026
Merck USD -1.28 3.32 Mar/2026
Nektar Therapeutics USD -1.35 1.17 Dec/2025
Neurocrine Biosciences USD 1.94 0.06 Mar/2026
Novartis USD 1.99 0.04 Mar/2026
Pfizer USD 0.75 0.09 Mar/2026
Roche Holding CHF 8.37 2.95 Dec/2025
Sarepta Therapeutics USD 3.16 6.74 Mar/2026
Takeda JPY -15.56 81.3 Mar/2026
Teva Pharmaceutical Industries USD 1.57 1.41 Mar/2026
Xencor USD -1.71 1.62 Mar/2026